| GENE_SYMBOL |
DRUG_NAME |
Ki (nM) |
IC50 (nM) |
Kd (nM) |
EC50 (nM) |
Potency (nM) |
AC50 (nM) |
Datasource |
| IRAK4 |
US11702414, Example 37 |
NA |
1000000 |
NA |
NA |
NA |
NA |
BindingDB |
| IRAK4 |
N-[3-ethyl-2-(3-hydroxy-3-methylbutyl)-6-(2-hydroxypropan-2-yl)benzimidazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide |
NA |
426000 |
NA |
NA |
NA |
NA |
BindingDB |
| IRAK4 |
(1R,2S,3R,5R)-3-[[5-(1,3-benzothiazol-2-yl)-2-(cyclopropylmethylamino)pyrimidin-4-yl]amino]-5-(hydroxymethyl)cyclopentane-1,2-diol |
NA |
333000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| IRAK4 |
(1R,2S,3R,5R)-3-[[5-(1,3-benzothiazol-2-yl)-2-(3-methoxypropylamino)pyrimidin-4-yl]amino]-5-(hydroxymethyl)cyclopentane-1,2-diol |
NA |
228000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| IRAK4 |
(1R,2S,3R,5R)-3-[[5-(1,3-benzothiazol-2-yl)-2-(oxan-4-ylamino)pyrimidin-4-yl]amino]-5-(hydroxymethyl)cyclopentane-1,2-diol |
NA |
1081000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| IRAK4 |
(1R,2S,3R,5R)-3-[[5-(1,3-benzothiazol-2-yl)-2-(cyclohexylamino)pyrimidin-4-yl]amino]-5-(hydroxymethyl)cyclopentane-1,2-diol |
NA |
3012000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| IRAK4 |
(1r,2s,3r,5r)-3-{[5-(1,3-Benzothiazol-2-Yl)-2-(Propylamino)pyrimidin-4-Yl]amino}-5-(Hydroxymethyl)cyclopentane-1,2-Diol |
NA |
1193000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| ITGA2B |
2-Benzyloxycarbonylamino-3-[4-(3-phenyl-propoxy)-phenyl]-propionic acid |
NA |
1000000 |
NA |
NA |
NA |
NA |
TTD |
| ITGA2B |
2-[5-[2-[[4-(1H-benzimidazol-2-ylamino)phenyl]methylamino]-2-oxoethyl]-6-oxo-11H-benzo[c][1]benzazepin-11-yl]acetic acid |
NA |
1000000 |
NA |
NA |
NA |
NA |
TTD |
| ITGA2B |
Arginyl-glycyl-aspartic acid |
NA |
130000|1000000 |
NA |
NA |
NA |
NA |
PubChem |
| ITGA2B |
3-{2-[(5-Carbamimidoyl-1H-indole-2-carbonyl)-amino]-2-methyl-propionylamino}-3-phenyl-propionic acid |
NA |
250000 |
NA |
NA |
NA |
NA |
TTD |
| ITGA2B |
2-[5-[2-[[4-(1H-benzimidazol-2-ylamino)cyclohexyl]methylamino]-2-oxoethyl]-6-oxo-11H-benzo[c][1]benzazepin-11-yl]acetic acid |
NA |
1000000 |
NA |
NA |
NA |
NA |
TTD |
| ITGA2B |
Ac-D-Arg-Gly-Asp-Ser-NH2 |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |
| ITGA2B |
Ac-Arg-Gly-Asp-D-Ser-NH2 |
NA |
138000 |
NA |
NA |
NA |
NA |
TTD |
| ITGA2B |
Ac-Arg-Arg-Gly-Asp-Phe-NH2 |
NA |
113000 |
NA |
NA |
NA |
NA |
TTD |
| ITGA2B |
Ac-Lys-Gly-Asp-Ser-NH2 |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |
| ITGA2B |
Ac-Cit-Gly-Asp-Ser-NH2 |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |
| ITGA2B |
Ac-His-Gly-Asp-Ser-NH2 |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |
| ITGA2B |
Ac-Arg-Pro-Asp-Ser-NH2 |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |
| ITGA2B |
Ac-Arg-Sar-Asp-Ser-NH2 |
NA |
200000 |
NA |
NA |
NA |
NA |
TTD |